低剂量瑞法布汀三联疗法(RHB - 105)根除幽门螺杆菌不受高体重指数的影响

GastroHep Pub Date : 2021-09-28 DOI:10.1002/ygh2.494

J. Kao, J. Almenoff, Dana D. Portenier, Kely L. Sheldon

{"title":"低剂量瑞法布汀三联疗法(RHB - 105)根除幽门螺杆菌不受高体重指数的影响","authors":"J. Kao, J. Almenoff, Dana D. Portenier, Kely L. Sheldon","doi":"10.1002/ygh2.494","DOIUrl":null,"url":null,"abstract":"Helicobacter pylori infection affects ~35% of Americans and may lead to serious sequelae if left untreated, including gastric cancer. Obesity is a significant risk factor for antibiotic treatment failure; however, little work has been done to understand the influence of high body mass index (BMI) on the success rates of H pylori eradication regimens in treatment‐naïve and refractory adult patients.","PeriodicalId":12480,"journal":{"name":"GastroHep","volume":"64 1","pages":"426 - 434"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Helicobacter pylori eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index\",\"authors\":\"J. Kao, J. Almenoff, Dana D. Portenier, Kely L. Sheldon\",\"doi\":\"10.1002/ygh2.494\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Helicobacter pylori infection affects ~35% of Americans and may lead to serious sequelae if left untreated, including gastric cancer. Obesity is a significant risk factor for antibiotic treatment failure; however, little work has been done to understand the influence of high body mass index (BMI) on the success rates of H pylori eradication regimens in treatment‐naïve and refractory adult patients.\",\"PeriodicalId\":12480,\"journal\":{\"name\":\"GastroHep\",\"volume\":\"64 1\",\"pages\":\"426 - 434\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GastroHep\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/ygh2.494\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GastroHep","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ygh2.494","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

幽门螺杆菌感染影响约35%的美国人，如果不及时治疗，可能导致严重的后遗症，包括胃癌。肥胖是抗生素治疗失败的重要危险因素;然而，关于高体重指数(BMI)对治疗naïve和难治性成人患者幽门螺杆菌根除方案成功率的影响的研究很少。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Helicobacter pylori eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index

Helicobacter pylori infection affects ~35% of Americans and may lead to serious sequelae if left untreated, including gastric cancer. Obesity is a significant risk factor for antibiotic treatment failure; however, little work has been done to understand the influence of high body mass index (BMI) on the success rates of H pylori eradication regimens in treatment‐naïve and refractory adult patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

GastroHep

自引率

0.00%

发文量